Wachtell, Lipton, Rosen & Katz represented OneTrust in the transaction. OneTrust LLC, an industry leader in privacy and security software, announced that its largest minority shareholders,...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz advised Warburg Pincus on the deal while Ropes & Gray advised K2 Insurance Services and Lee Equity Partners. K2 Insurance Services,...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz advised BGC Partners on the matter. Debevoise & Plimpton advised a Joint Committee of the Board of Directors of BGC Partners....
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised ACELYRIN on the deal. ACELYRIN announced the completion of its $300 million Series C financing round which was led by Access Biotechnology with participation...
You must be a Standard 1 Year member to access this content.
Wachtell Lipton and Skadden advised Adobe on the deal. Fenwick & West advised Sigma while Gunderson Dettmer represented clients Index Ventures, Kleiner Perkins and Greylock Partners....
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Medipost Co. on the deal. Medipost Co. announced its strategic agreement with OmniaBio, Inc., a subsidiary of the Centre for Commercialization of Regenerative Medicine...
You must be a Standard 1 Year member to access this content.
Willkie Farr & Gallagher represented Truist Insurance Holdings, Jones Day represented BenefitMall, while Wachtell, Lipton, Rosen & Katz advised Carlyle on the deal. Truist Insurance Holdings,...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz advised Prologis, while Hogan Lovells US and Alston & Bird advised Duke Realty on the deal. Fried Frank acted as counsel...
You must be a Standard 1 Year member to access this content.
Goodwin advised Nuvig Therapeutics on the deal. Nuvig Therapeutics announced its $47 million Series A financing and the launch of the company to develop novel therapeutics that...
You must be a Standard 1 Year member to access this content.
Goodwin advised Tessera Therapeutics on the deal. Tessera Therapeutics announced its Series C financing, which totaled over $300 million. Tessera is a biotechnology company pioneering a...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz and Maples and Calder represented Social Capital Suvretta Holdings Corp. I in the transaction. Goodwin Procter advised Akili, while Skadden, Arps,...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised SWORD Health on the deal. SWORD Health announced its Series D financing. This brings the total primary and secondary transactions to more than $320...
You must be a Standard 1 Year member to access this content.
